- Home
- LEGN vs LEU Comparison
LEGN vs LEU Comparison
Compare LEGN & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- LEU
- Stock Information
- Founded
- LEGN 2014
- LEU 1998
- Country
- LEGN United States
- LEU United States
- Employees
- LEGN N/A
- LEU N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- LEGN Health Care
- LEU Industrials
- Exchange
- LEGN Nasdaq
- LEU Nasdaq
- Market Cap
- LEGN 6.3B
- LEU 5.6B
- IPO Year
- LEGN 2020
- LEU 1998
- Fundamental
- Price
- LEGN $31.46
- LEU $369.00
- Analyst Decision
- LEGN Strong Buy
- LEU Buy
- Analyst Count
- LEGN 12
- LEU 11
- Target Price
- LEGN $73.36
- LEU $194.80
- AVG Volume (30 Days)
- LEGN 1.2M
- LEU 1.5M
- Earning Date
- LEGN 11-11-2025
- LEU 10-27-2025
- Dividend Yield
- LEGN N/A
- LEU N/A
- EPS Growth
- LEGN N/A
- LEU 10.12
- EPS
- LEGN N/A
- LEU 6.16
- Revenue
- LEGN $796,838,000.00
- LEU $436,900,000.00
- Revenue This Year
- LEGN $69.31
- LEU $3.52
- Revenue Next Year
- LEGN $52.73
- LEU $8.01
- P/E Ratio
- LEGN N/A
- LEU $60.25
- Revenue Growth
- LEGN 74.75
- LEU 12.72
- 52 Week Low
- LEGN $27.34
- LEU $49.40
- 52 Week High
- LEGN $51.77
- LEU $388.62
- Technical
- Relative Strength Index (RSI)
- LEGN 31.45
- LEU 74.97
- Support Level
- LEGN $32.02
- LEU $303.58
- Resistance Level
- LEGN $32.62
- LEU $338.00
- Average True Range (ATR)
- LEGN 1.02
- LEU 29.88
- MACD
- LEGN -0.09
- LEU 6.46
- Stochastic Oscillator
- LEGN 6.87
- LEU 86.04
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.